US7449008B2 - Drug infusion device with tissue identification using pressure sensing - Google Patents

Drug infusion device with tissue identification using pressure sensing Download PDF

Info

Publication number
US7449008B2
US7449008B2 US10/827,969 US82796904A US7449008B2 US 7449008 B2 US7449008 B2 US 7449008B2 US 82796904 A US82796904 A US 82796904A US 7449008 B2 US7449008 B2 US 7449008B2
Authority
US
United States
Prior art keywords
fluid
pressure
sensor
tissue
pumping mechanism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US10/827,969
Other versions
US20050004514A1 (en
Inventor
Mark N. Hochman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Milestone Scientific Inc
Original Assignee
Milestone Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/201,464 external-priority patent/US6200289B1/en
Application filed by Milestone Scientific Inc filed Critical Milestone Scientific Inc
Priority to US10/827,969 priority Critical patent/US7449008B2/en
Priority to PL04783761T priority patent/PL1670522T3/en
Priority to KR1020067006951A priority patent/KR101104523B1/en
Priority to CN200480030713A priority patent/CN100581613C/en
Priority to CA2539106A priority patent/CA2539106C/en
Priority to DE602004024098T priority patent/DE602004024098D1/en
Priority to PCT/US2004/029665 priority patent/WO2005027992A2/en
Priority to BRPI0414352A priority patent/BRPI0414352B8/en
Priority to ES04783761T priority patent/ES2335348T3/en
Priority to DK04783761.2T priority patent/DK1670522T3/en
Priority to AT04783761T priority patent/ATE447996T1/en
Priority to EP04783761A priority patent/EP1670522B1/en
Priority to MXPA06002764A priority patent/MXPA06002764A/en
Priority to JP2006526333A priority patent/JP4722849B2/en
Assigned to MILESTONE SCIENTIFIC, INC. reassignment MILESTONE SCIENTIFIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOCHMAN, MARK N.
Publication of US20050004514A1 publication Critical patent/US20050004514A1/en
Priority to US11/208,400 priority patent/US20060122555A1/en
Priority to US11/271,563 priority patent/US7625354B2/en
Priority to IL174302A priority patent/IL174302A/en
Priority to HK07110728.1A priority patent/HK1106457A1/en
Publication of US7449008B2 publication Critical patent/US7449008B2/en
Application granted granted Critical
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16854Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3478Endoscopic needles, e.g. for infusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3344Measuring or controlling pressure at the body treatment site

Definitions

  • the present invention relates generally to improvements to the delivery of drugs, particularly to systems for subcutaneous injection/aspiration. More specifically this invention provides a method and device to the identification of specific tissue types (or soft-tissue density types) based on using a pressure measurement.
  • Infusion pumps devices and systems are well known in the medical arts, for use in delivery or dispensing a prescribed medication to a patient.
  • the administration of prescribed drugs has been described in the literature as administration to a patient through infusion tubing and an associated catheter or the like, thereby introducing the drug intravenously.
  • These systems are usual capable of determining infusion line occlusion. Line occlusions cause the pressure in the syringe to increase.
  • Systems in the prior art have been developed to identify a predetermined threshold or to monitor pressure to determine means for selecting ranges of occlusion pressures to insure patient safety.
  • 5,295,967; 4,731,058; and 5,080,653 show systems (with syringe pumps or the like) which are adequate for the intended use of intravenous drug delivery and more specifically for monitoring occlusion during infusion.
  • these systems do not provide a means for drug delivery or aspiration subcutaneously via a hypodermic needle.
  • Subjective pain response of a patient has been demonstrated to be minimized at specific flow rates during the administration of a drug.
  • particular pressures excessive without occlusion, per se
  • 6,113,574 to Spinello discloses an injection device in which a pressure sensor switch is used to determine during a PDL injection whether the liquid from a needle is injected into the proper location, or is leaking out into a patient's mouth or to some other location.
  • the patent does not address the problem of identifying the tissue in which an injection is being made.
  • U.S. Pat. No. 6,200,2108 a parent of the present application and incorporated herein by reference, discloses an automatic injection device that includes a drive mechanism that causes a therapeutic fluid to flow from a cartridge supported by a cartridge holder, a tube and a handle with an injection needle.
  • the drive mechanism is connected to an electric motor and a sensor positioned at the motor output that measures the force applied by the motor to the drive mechanism. This force is then used to determine an internal characteristic such as a force or internal pressure generated during the injection process.
  • This characteristic is then used as a control parameter by a microprocessor or controller which generates corresponding commands to the drive mechanism.
  • the characteristic is used to calculate an exit pressure at which fluid ejected by the device through an elongated tube.
  • the electric motor is then operated in such a manner that the exit pressure is maintained at a predetermined level to insure that a patient does not suffer pain and/or tissue damage.
  • the present invention provides a method and device that enables the practitioner to utilize a diagnostic and therapeutic device simultaneously.
  • the current device utilizes the inherent tissue density or resistance of fluid pressure within that tissue to identify the accuracy of placement of a needle within specific tissues.
  • Each tissue has its own pressure density characteristics which are represented as measurable pressures that can be elicited within a given tissue type.
  • the density or resistance of the tissue is measured using the pressure/force of a fluid infused from a computer-controlled drug delivery system capable of detecting pressure resistance during infusion.
  • the pressure resistance measure is converted into a visual as well as audible signal on a continuous basis.
  • the measurements are then presented to the doctor so that the doctor can determine or confirm whether the injection is being delivered to the right tissues. In addition, the measurements are also recorded for later review and documentation of the clinical event.
  • Upper limits of pressure as well as control of flow-rate can be pre-defined to ensure that excessive pressure and/or flow-rate are not used during this process.
  • the present application also provides alternate means of determining force or pressure within an automatic injection device.
  • the electrical energy or power used by the motor is used as a parameter indicative of the force.
  • a change in a dimension of various elements of the fluid delivery system are used as parameters. This dimensional change is then converted into signal indicative of the internal force/pressure.
  • some of the elements that exhibit dimensional changes responsive to increased internal forces or pressures include the cartridge or reservoir holder, including its wings, the tube used to deliver the drug from the cartridge to the handpiece, the needle hub and/or its elements.
  • the sensor for determining this dimensional variation may be for example an optical sensor.
  • a third method is to determine the stress or strain on the motor housing and/or the supporting members of the drive.
  • a standard electronic strain gauge may be used for making this measurement.
  • a system in accordance with this invention for dispensing a fluid by injecting the same into a patient includes a mechanical assembly and an electrical controller.
  • the mechanical assembly consists of a drive mechanism and a disposable portion consisting of a fluid storage device such as a syringe, a carpule and the like, and a fluid delivery section including a tube coupled to said fluid storage device and terminating in a needle adapted to be inserted into the subject tissue.
  • the drive mechanism includes a housing with an internal motor and a mount for mounting the fluid storage device on the housing.
  • the fluid storage device includes a reciprocating plunger. A coupling is used to move the plunger with said motor. If a carpule is used for the fluid storage device, an adapter is also provided to allow the same mount to secure the carpule as well.
  • the mount is arranged and constructed to secure syringes or carpules having a large variety of sizes.
  • a transducer is used to sense the force or pressure generated by the motor and applied by the plunger within the fluid storage device.
  • the transducer measures the force between the carpule adapter and the remaining housing of the device.
  • the transducer includes a size sensing device that senses a change in dimension of an element of the device, said change being indicative of the force or pressure of the drug within the system and the exit pressure.
  • the change in size of the tubing may be used as an indicia of this force or pressure.
  • the pressure within the tube is measured externally and used as a means of determining the exit pressure.
  • the motor, the coupling associated with the motor and the electronic controller discussed below is at least partially disposed within the housing for protection.
  • the fluid storage device is filled and a setup process is initiated during which various operational parameters are calculated, retrieved or received from the clinician.
  • the clinician also specifies the fluid flow rates and peak exit pressure and a total amount of fluid to be dispensed. Then he operates a pneumatic control such as a foot pedal and initiates the fluid flow. Alternatively, commands may be initiated by the clinician either electronically or by voice commands.
  • the output from the transducer is used to calculate the current exit fluid pressure. If this exit pressure approaches a certain threshold, the fluid flow rate is automatically reduced to prevent excessive exit pressure, thereby ensuring that the patient does not suffer undue pain and no tissue is damaged.
  • Several optional features are also provided including aspiration, purging or charging the media with or without air.
  • the system may be operated in a biopsy mode in which the entry pressure and the outbound or withdrawn fluid flow rate are the relevant control parameters.
  • the clinician is provided with constant current information on the ongoing process, both visual and aurally, including the current flow rate, total volume ejected or aspired, exit or entry pressures and other parameters.
  • the slave microprocessor receives commands from the master microprocessor and generates the drive signals required to operate the motor.
  • FIG. 1 shows a diagram illustrating the major components of the infusion device constructed in accordance with this invention
  • FIG. 2 shows an orthogonal view of the drive mechanism of FIG. 1 ;
  • FIG. 3 shows internal details of the drive mechanism of FIG. 1 ;
  • FIG. 3A shows a block diagram of the electronic controller of FIG. 1 ;
  • FIG. 4 shows a side view of the housing of a different type of infusion device with an adapter for pressure sensing
  • FIG. 5 shows an end view of the housing of FIG. 4 ;
  • FIG. 6 shows an enlarged view of the adapter of FIG. 4 ;
  • FIG. 7 shows a somewhat diagrammatic cross-sectional view of the housing of FIG. 4 ;
  • FIG. 8 shows an alternate embodiment of a pressure gauge using the size of the tubing
  • FIG. 9 shows another embodiment of the pressure gauge using the size of the tubing
  • FIG. 10 shows a graph of typical pressure ranges for injections into four different types of tissues.
  • the subject invention pertains to a system for delivering drugs such as an anesthetic, under pressure into a patient's tissues.
  • drugs such as an anesthetic
  • injected fluid disperses through a tissue at different rates, causing the fluid exit pressure to vary.
  • This exit pressure (or an internal pressure related to the exit pressure) is indicative of, and may be used to identify several types of tissues.
  • FIGS. 1 and 2 The mechanical assembly for the subject system is illustrated in FIGS. 1 and 2 and the electronic controller 150 for the system is shown in FIG. 3 .
  • a drug delivery system 10 constructed in accordance with this invention includes drive mechanism 12 , a delivery tube 14 and a handle 16 terminating with a needle 17 . More particularly, a syringe 90 (or other fluid storage device or container) is mounted on the drive mechanism with one end of tube 14 being coupled to the syringe 90 .
  • the tube 14 , handle 16 and needle 17 in the embodiments of FIGS. 1 to 3 form injection means of the invention for administering the drug fluid at a dynamic exit fluid pressure to a patient tissue type for receiving the drug fluid.
  • the drive mechanism 12 operates a plunger 94 to selectively eject fluid out of the syringe 90 , through the tube 14 , handle 16 , and needle 17 or alternatively to draw fluid in.
  • the drive mechanism 12 , plunger 94 and syringe 90 form a pumping mechanism for the device.
  • the drive mechanism 12 is associated with an external controller for selecting various operational parameters discussed in more detail below.
  • This external controller may be provided on the housing of the drive mechanism or may be provided as a separate control unit 18 coupled to the drive mechanism 12 by a cable 20 .
  • the control unit 18 may be for instance a PC or laptop computer. Alternatively, the control unit 18 may be internal.
  • the drive mechanism 12 includes a housing 22 with a top surface 24 and intermediate surface 26 disposed below top surface 24 . On surface 26 there is formed a rail 28 extending along the longitudinal axis of housing 22 . A platform 30 which is disposed on the rail 28 can be reciprocated back and forth in parallel with said longitudinal axis, as described in more detail below.
  • the clamp 40 On top surface 24 there is a clamp 40 .
  • the clamp 40 has a generally C-shaped body.
  • a screw with a head 48 extends through a threaded hole (not shown) in the body of the clamp 40 .
  • Platform 30 has a slot 56 .
  • a motor 66 ( FIG. 3 ). Threaded through the motor 66 there is a worm screw 72 .
  • the worm screw 72 is arranged so that as the motor 66 is activated, the worm screw 72 moves in one direction or another, dependent on its direction of rotation, in parallel with the longitudinal aids of the housing 22 .
  • One end of the worm screw 72 is non-rotatably attached to a pad 74 , coupled to a platform 76 .
  • Two short rods 80 are used to couple the pads 74 to platform 76 , to prevent the transmission of rotational forces generated by the motor 66 to the platform 76 .
  • Rods 82 , 84 extend between platforms 30 and 76 and secure these two members together. These rods 82 , 84 are slidably supported by two pairs of bushings 68 , 70 on the housing 22 . Except for these bushings, the platforms 76 and 30 are floating respectively inside and outside the housing 22 . Rods 82 , 84 extend through wall 86 extending between surfaces 24 and 26 via holes (not shown). The rail 28 is hollow and aligned with the worm screw 72 to allow the worm screw 72 to move longitudinally along its axis through the housing 22 .
  • the syringe 90 has a barrel 92 on surface 24 .
  • the barrel 92 has a finger tab resting in a slot formed on the face 24 .
  • the finger tab and the slot have been omitted from the drawings for the sake of clarity.
  • the syringe 90 also includes a plunger 94 reciprocated within the barrel 92 by a shaft 93 .
  • the shaft terminates in a finger pad 96 resting in slot 56 of platform 30 .
  • the syringe 90 is secured to the housing 22 by clamp 40 and screw 48 .
  • the syringe terminates with a Luer lock 95 used to connect the syringe to tube 14 .
  • the motor 66 When the motor 66 is activated, as discussed below, it forces the worm screw 72 to move in one direction or another.
  • the worm screw in turn forces the platforms 30 , 76 and rods 82 and 84 to move in concert as well, thereby forcing the plunger 94 to reciprocate within the barrel 92 .
  • the only elements which move in and out of the housing are the rods 82 , 84 .
  • the drive mechanism 12 is adapted to receive and operate with syringes of various diameters and lengths.
  • the delivery tube 14 , handle 16 and needle 17 may have any size desired.
  • the apparatus includes a pair of pressure sensors 78 A are disposed between finger pad 96 and the walls of slot 56 .
  • the sensors 78 A are arranged to measure the force applied between the platform 30 and the finger pad 96 .
  • sensors 78 B are provided between the bushings 68 and the sidewalls of the housing 22 . In this manner, the sensors 78 B can measure the force (or strain) resultant from the force applied by the motor on the syringe plunger 94 .
  • a similar load cell may be placed between the syringe tab and the housing 22 .
  • the sensors may be load cells, for instance a Model S400 load cell made by the SMD, Inc. of Meridien, Conn.
  • the tubing 14 passes through a hole in a size gauge 54 .
  • the size gauge 54 monitors the size (e.g. cross-sectional dimension, or diameter) of the tubing 14 and provides this parameter to the master controller 18 .
  • gauge 54 may include one or more LEDs and an array of light sensors with tubing disposed therebetween. The size of the tubing is determined by the number and/or position of the light sensors occluded by the tubing.
  • FIG. 8 shows a cross-section of another gauge 54 A that may be used instead of gauge 54 . It consists of a base B with a slot S holding the tubing T. A hinged cover C holds the tubing T in place. A force sensor FS available off the shelf is inserted through a hole H and rests against the tubing T. As the tubing expands and contracts due to pressure changes, it applies a force on the force sensor. Experimental data shows that this gauge 54 A has a fairly linear output and easy to calibrate for various pressures.
  • FIG. 9 shows another gauge 54 B that can be used instead of gauge 54 .
  • This gauge is similar to the one in FIG. 8 with the exception that a groove is made in the cover C and the tube is resting on a floating platform P disposed above the force sensor. The force generated by the pressure within the tube is transmitted by the floating platform P to the force sensor FS. Again, the response of this gauge is linear and easy to calibrate.
  • FIG. 3A shows a block diagram of the electronic controller 150 .
  • the controller 150 includes two microprocessors: a master microprocessor 152 and a slave microprocessor 154 .
  • Slave microprocessor 154 is used to derive the signals that actually drive the motor 66 and to collect information regarding the position of the platforms 30 , 76 .
  • the master microprocessor 152 is used to collect information regarding the rest of the system, including the syringe 90 , and its contents, the tube 14 , the handle 16 and so on, and to generate control signals for the slave microprocessor 154 necessary for operating the motor 66 to deliver the contents of the syringe 90 .
  • the slave microprocessor 154 and its associated circuitry are disposed within the housing 22 .
  • the master microprocessor 152 is incorporated into control unit 18 which is coupled to the housing 22 through cable 20 as shown in FIG. 1 .
  • the microprocessor 152 is associated with a memory 160 , input devices 162 , display devices 164 and an interface 164 .
  • Memory 160 is used to store programming and data for the master microprocessor 152 . More specifically, the memory 160 is used to store six or more data banks, each of said data banks being dedicated to the following information: (a) syringes; (b) tubing; c) needles; (d) fluids; (e) governor parameters; and (f) profiles consisting of a plurality of parameters for a particular procedure to be performed. Each of these parameters is used to determine the control signals generated for the slave microprocessor 154 . Each of these data banks contains the appropriate parameters for various commercially available products, or alternatively, parameter data derived using a specific algorithm. Information regarding the various elements for a particular configuration is entered through input devices 102 and is confirmed on the display device 164 . These input devices may include a keyboard, a touch screen, a mouse, as well as a microphone. If a microphone is included, voice commands are interpreted by a voice recognition circuit 162 A.
  • the display device 164 is further used to provide an indication as well as instructions on the operation of the system 10 .
  • the commands for the operation of motor 66 are generated by master microprocessor 152 and transmitted to an interface 162 .
  • Microprocessor 152 is further provided with a speaker 165 used to provide various oral messages, including spoken pre-recorded or synthesized words, (generated by a voice synthesized circuit 165 A) chimes, and so on, to provide instructions to the clinician and to provide other information about the current status of the whole system and its elements without the need for the clinician to look at the displays all the time.
  • the slave microprocessor 154 receives these commands through cable 20 or other connection means and interface 170 .
  • foot pedal 176 consists of an air chamber with a flexible side wall, said side wall being arranged to change the volume of air and pressure within said chamber in response to activation by a human operator.
  • a pressure sensor (not shown) is part of the foot pedal and is arranged to provide information about said pressure to slave microprocessor 154 via a corresponding A/D converter 190 . Foot pedals of this kind are well known in the art and therefore its details have been omitted.
  • the power required to drive motor 66 is monitored.
  • the master controller 150 maybe provided with a power meter P that monitors this power, for example, by measuring the voltage and current applied thereto.
  • This power is, of course, indicative of the force applied by the motor and is used in the same manner as the output of the sensors 78 A, 78 B or 54 .
  • a sensor module is added on top of the housing.
  • the housing 300 has a top surface 302 and a front surface 304 . Disposed on the front surface 304 there are a plurality of indication lights and one or more control buttons 308 .
  • a sensor module 310 is mounted on top surface 302 .
  • This module 310 includes its own upper surface 312 and front surface 314 .
  • a cartridge 322 attached to module 310 there is a cartridge 322 connected to the proximal end of a tubing 324 .
  • the distal end of the tubing 324 is connected to a needle, a catheter or other similar injection means that are similar to the tube 14 , handle 16 and needle 17 of the embodiments of FIGS. 1 to 3 , for administering the drug fluid at a dynamic exit fluid pressure to a patient tissue type for receiving the drug fluid.
  • this injection means can be stored in hole 320 .
  • the bottom 326 of the cartridge holder 322 is shaped so that it can be inserted quickly and easily into the receptacle 318 and form an interference fit therewith. As described in U.S. Pat. No. 6,152,734, preferably a quick-connect coupling is provided between the bottom 328 and the receptacle 318 so that the cartridge holder 322 can be quickly and easily installed onto and removed from the receptacle.
  • the cartridge holder 322 holds a cartridge with an anesthetic or other medicinal substance (not shown).
  • one or more sensors 328 are positioned between the bottom 326 of cartridge holder and the walls of receptacle 318 . These sensors may be pressure sensors or other similar sensors used to monitor the force applied to the liquid being ejected through tubing 324 .
  • a plunger 332 disposed in housing 300 there is a plunger 332 , which, with the cartridge 322 and a motor 334 , form the pumping mechanism for this embodiment of the invention.
  • Module 312 holds optionally a plunger sensor 330 that is disposed in close proximity to, or in contact with the plunger 332 .
  • a plunger sensor 330 that is disposed in close proximity to, or in contact with the plunger 332 .
  • the plunger sensor 330 measures the direction and, optionally, the rate of movement of the plunger 332 .
  • This plunger 332 is reciprocated vertically by a motor 334 .
  • the motor 334 is controlled by a controller 336 .
  • the sensors 328 and 330 are coupled to an interface 338 .
  • This interface transmits the information from the sensors 348 , 330 to the controller 336 .
  • the controller then operates the motor to cause the plunger 332 in the same manner, and using the same algorithm as the plunger 94 in FIGS. 1-4 .
  • the information associated with this operation, and any other information are displayed on the display 316 .
  • the sensors may also be used to detect basic operations of the unit such as purging or auto-retraction of this plunger.
  • basic operations of the unit such as purging or auto-retraction of this plunger.
  • the pressure sensors detect their placement and will then automatically purge air from the tubing line readying the system for use.
  • the pressure sensor can detect the removal and allow for automatic retraction of the plunger to the “home” position.
  • the pressure sensors play a multipurpose role of detecting exit pressure as well as basic operations of the drive unit.
  • the pressure may also be used as criteria to determine the tissue in which fluid is being injected by the device.
  • Previous authors have investigated the clinical implications of interstitial pressure during dental injections. The present inventor has conducted research that demonstrates that using the device described herein, subcutaneous interstitial pressures could be accurately measured and recorded in real-time. It was also determined that a given range of pressures obtained with the device could be readily identified and associated with for specific tissue types. Interstitial pressures generated were correlated to the tissue densities type for particular anatomic locations.
  • Highly organized densely packed collagen fibers such as those found in certain oral tissues as in the periodontal ligament and gingival hard palate reduced the ability for diffusion of injected fluid, i.e. fluids are contained within a smaller area.
  • This reduced ability for denser tissues to allow rapid re-distribution of the drug results in higher internal pressure during injections.
  • loosely organized tissues with a connective stroma composed of a collagen matrix interposed with interstitial fluid and adipose tissues as those found in the mucobuccal fold and infratemperal fossa result in lower interstitial pressure, as a result of the drug being spread through a larger tissue area.
  • FIG. 10 shows the various pressures obtained during these injections, and clearly illustrates the concept of using pressure (preferably exit pressure) as a means of identifying tissues.
  • tissues may be categorized into the following types:
  • Type 1 Low density tissues, comprised of a loosely organized connective tissue matrix interposed with adipose tissue, intercellular fluids and small volumes of organized collagen fibers present.
  • tissue type are subcutaneous connective tissues of the maxillary buccal mucosa and infratermporal fossa. Examples of injections performed in these tissue types include; buccal infiltration and inferior alveolar nerve block.
  • Type 2 Moderate density tissues, comprised of a combination of densely packed collagen fiber bundles interposed with a small amount of glandular tissues and/or adipose tissue. A relatively small amount of intercellular fluids are found in these tissues. Moderate density tissues would also be represented by muscular tissue of the oral cavity. A moderate degree of collagen organization is found in these types of tissues.
  • the tissue types are represented by the attached palatal gingiva, attached gingival tissues or muscle tissues of the oral cavity. Examples of injections performed in these tissue types include; palatal injections or injections into the attached gingiva.
  • Type 3 High density tissue composed of predominately dense highly organized collagen fiber matrixes. Examples of these types of tissues are the periodontal ligament and the muscle tendon attachments, an example of an injection performed in this tissue type is the PDL injection.
  • the injection device continuously monitors a pressure, and preferably the exit pressure of the fluid during injection. Based on tables stored in its memory, the device is able to determine the type of tissues in which the injection is being injected. This information is displayed to the doctor (or other clinician). The doctor can then confirm that he is performing the injection in the desired tissues. In addition, for each type of tissue, preselected maximum allowable pressure limits and/or flow rates are stored that define either the maximum recommended pressures that patients usually tolerate, or other criteria. The parameters are stored in memory 160 . As the pressure approaches this limit, a visual and/or audible alarm is generated for the clinician. In addition, data descriptive of the whole injection process is stored for future analysis, as discussed above.

Abstract

An automatic injection device includes a drive mechanism and a sensor used to determine an internal characteristic such as a force or internal pressure generated during an injection process. This characteristic is then used as a control parameter by a microprocessor or controller to determine the exit pressure of the fluid expelled by the device. This exit pressure is then used to identify the kind of tissue in which the injection is being introduced.

Description

RELATED APPLICATION
This application claims priority to U.S. Provisional application Ser. No. 60/502,379 filed Sep. 12, 2003 and incorporated herein by reference.
This application is also a continuation in part application to application Ser. No. 09/766,772 filed Jan. 22, 2001 now U.S. Pat. No. 6,786,885, which is a divisional of application Ser. No. 09/201,464 filed Nov. 30, 1998 now U.S. Pat. No. 6,200,289 claiming priority to provisional application Ser. No. 60/081,388 filed Apr. 10, 1998, all incorporated herein by reference.
BACKGROUND OF THE INVENTION
a. Field of Invention
The present invention relates generally to improvements to the delivery of drugs, particularly to systems for subcutaneous injection/aspiration. More specifically this invention provides a method and device to the identification of specific tissue types (or soft-tissue density types) based on using a pressure measurement.
b. Description of the Prior Art
Infusion pumps devices and systems are well known in the medical arts, for use in delivery or dispensing a prescribed medication to a patient. The administration of prescribed drugs has been described in the literature as administration to a patient through infusion tubing and an associated catheter or the like, thereby introducing the drug intravenously. These systems are usual capable of determining infusion line occlusion. Line occlusions cause the pressure in the syringe to increase. Systems in the prior art have been developed to identify a predetermined threshold or to monitor pressure to determine means for selecting ranges of occlusion pressures to insure patient safety. U.S. Pat. Nos. 5,295,967; 4,731,058; and 5,080,653 show systems (with syringe pumps or the like) which are adequate for the intended use of intravenous drug delivery and more specifically for monitoring occlusion during infusion. However, these systems do not provide a means for drug delivery or aspiration subcutaneously via a hypodermic needle.
Accurately positioning a hollow-bore needle within tissues to delivery medication within tissue structures has long been a challenge in both medicine and dentistry. The inability to accurately position a hollow-bore needle within specific tissues (i.e. soft-tissues) or organs can lead to a failed medical objective. Locating pathologic tissue types (i.e. neoplasia, tumors, cysts and the like) is critical to aspiration of these tissues as well as the infusion of therapeutic medications to treat these local lesions of the body. Hence locating a specific anatomically site has been previously assisted with the use of ionizing radiation, ultrasound, MRI, electrical-stimulators and other invasive diagnostic devices that require secondary techniques to be employed to assist the practitioner to determining the accuracy of the placement of a needle within tissue.
Pain, tissue damage and post-op complications have long been tolerated as negative side effects from the use of existing hypodermic drug delivery injection systems. This is well documented in both the dental and medical literature. The pain and tissue damage are a direct result of uncontrolled flow rate in conjunction with excessive pressures created during the administration of drug solutions within the tissue spaces. Subjective pain response of a patient has been demonstrated to be minimized at specific flow rates during the administration of a drug. Also, it has been scientifically demonstrated that particular pressures (excessive without occlusion, per se) for a specific tissue type will cause damage. However, the present inventor has discovered that the amount of pain felt by a patient can be minimized with the use of a specific flow rate range in conjunction with a specified exit pressure range during the delivery of fluids (drugs). Moreover when drugs are delivered at this prescribed low ranges of pressure and fluid flow, tissue damage is minimized as well. It is also necessary that this system have the capability to aspirate under controlled conditions of rate and pressure to avoid the same negative side effects during fluid movement. U.S. Pat. No. 5,180,371 to Spinello, incorporated herein by reference, presented an invention, which allowed a rate to be set for the drug via a hypodermic needle. That invention however did not disclose means of determining, detecting or monitoring pressure during the administration of a drug. U.S. Pat. No. 6,113,574 to Spinello discloses an injection device in which a pressure sensor switch is used to determine during a PDL injection whether the liquid from a needle is injected into the proper location, or is leaking out into a patient's mouth or to some other location. However, the patent does not address the problem of identifying the tissue in which an injection is being made.
During the early 1980's, several researchers ( See for instance Rood, The Pressure Created by Inferior Alveolar Injections, British Dental J. 144:280-282 (1978); Walton and Abbot, Periodontal Ligament Injection; a Clinical Evaluation JADA. (October 1981); Smith and Walton, Periodontal Ligament Injection; Distribution of Injected Solution Oral Surg 55:232-238 (1983)) clearly demonstrated and concluded that the pressure created by the injected fluid is critical to preventing tissue damage and a pain response. Variability, different collagen types and connective tissue densities result in different tissue compliance and distensibility. These variations are found between subjects and within the individual subjects. Rood in his 1978 article states that “[t]he relationship between rate of injection and pressure rise seen clearly with the smaller volumes was lost when 2.0 ml was injected. Several high pressures were recorded and some unexpected low ones. Many tracings showed a pattern suggestive of tissue disruption and it is possible that said low pressures were due to the fluid no longer being contained within the pterygomandible space as the volume injected was similar to the previously estimated volume of the tissue space.” Hence, it appears that the rate of flow is not directly related to pressure during an interstitial injection.
Smith and Walton described in their article identified supra discussed above that they have performed a histologic animal study (canines) using a technique to calibrate manual pressures produced. They concluded that the “Volume injected and needle location were not always related to distribution. Injecting under moderate to strong back pressure gave deeper and more widespread dye penetration.” This once again confirms that pressure is the critical variable in the distribution of the solution within tissues and the volume is not always related to the pressure produced.
Pashley, Nelson & Pashley in “Pressures Created by Dental Injections” (J Dent Res 1981) used a pressure transducer and fixed flow rate created by a motor driven traditional syringe clearly demonstrated that different tissues have different tissue compliance. Interstitial pressure variability was statistically and clinically significant even with a fixed flow rate. Therefore, it may be concluded that they produced great variations of pressure by using a metered flow rate.
Pertot and Dejou described in their article “Effects of the force developed during periodontal ligament injections in dogs” (Oral Surg. Oral Med, Oral Pathol. 1992) how they used a syringe coupled to a miniature force transducer and found a positive correlation between the number of osteoclasts and the force applied on the syringe plunger, which indicated the pressure generated in the PDL space enhanced osteoclastic activity. This experiment again indicates that pressure is a critical factor to tissue damage and is dependent on the resistance encountered and not the flow rate of the solution into the tissues.
Prior art references are known which attempt to utilize a pressure transducer to measure the pressure within the syringe (See for instance U.S. Pat. No. 5,295,967). A major deficiency of these systems is their inability to adjust the flow rate and/or pressure of the fluid to compensate for changes in resistances throughout the system, or to the exit pressure. (Exit pressure refers to the fluid pressure just downstream of the needle tip within the patient's body). Moreover, the prior art references fail to provide any means of determining this exit pressure.
U.S. Pat. No. 6,200,218, a parent of the present application and incorporated herein by reference, discloses an automatic injection device that includes a drive mechanism that causes a therapeutic fluid to flow from a cartridge supported by a cartridge holder, a tube and a handle with an injection needle. The drive mechanism is connected to an electric motor and a sensor positioned at the motor output that measures the force applied by the motor to the drive mechanism. This force is then used to determine an internal characteristic such as a force or internal pressure generated during the injection process. This characteristic is then used as a control parameter by a microprocessor or controller which generates corresponding commands to the drive mechanism. In a particularly advantageous embodiment, the characteristic is used to calculate an exit pressure at which fluid ejected by the device through an elongated tube. The electric motor, is then operated in such a manner that the exit pressure is maintained at a predetermined level to insure that a patient does not suffer pain and/or tissue damage.
SUMMARY OF THE INVENTION
The present invention provides a method and device that enables the practitioner to utilize a diagnostic and therapeutic device simultaneously. The current device utilizes the inherent tissue density or resistance of fluid pressure within that tissue to identify the accuracy of placement of a needle within specific tissues. Each tissue has its own pressure density characteristics which are represented as measurable pressures that can be elicited within a given tissue type. The density or resistance of the tissue is measured using the pressure/force of a fluid infused from a computer-controlled drug delivery system capable of detecting pressure resistance during infusion. The pressure resistance measure is converted into a visual as well as audible signal on a continuous basis. The measurements are then presented to the doctor so that the doctor can determine or confirm whether the injection is being delivered to the right tissues. In addition, the measurements are also recorded for later review and documentation of the clinical event. Upper limits of pressure as well as control of flow-rate can be pre-defined to ensure that excessive pressure and/or flow-rate are not used during this process.
The present application also provides alternate means of determining force or pressure within an automatic injection device. In one embodiment, the electrical energy or power used by the motor is used as a parameter indicative of the force. In another embodiment, a change in a dimension of various elements of the fluid delivery system are used as parameters. This dimensional change is then converted into signal indicative of the internal force/pressure. For example, some of the elements that exhibit dimensional changes responsive to increased internal forces or pressures include the cartridge or reservoir holder, including its wings, the tube used to deliver the drug from the cartridge to the handpiece, the needle hub and/or its elements. The sensor for determining this dimensional variation may be for example an optical sensor.
A third method is to determine the stress or strain on the motor housing and/or the supporting members of the drive. A standard electronic strain gauge may be used for making this measurement.
Briefly, a system in accordance with this invention for dispensing a fluid by injecting the same into a patient includes a mechanical assembly and an electrical controller. The mechanical assembly consists of a drive mechanism and a disposable portion consisting of a fluid storage device such as a syringe, a carpule and the like, and a fluid delivery section including a tube coupled to said fluid storage device and terminating in a needle adapted to be inserted into the subject tissue. The drive mechanism includes a housing with an internal motor and a mount for mounting the fluid storage device on the housing. The fluid storage device includes a reciprocating plunger. A coupling is used to move the plunger with said motor. If a carpule is used for the fluid storage device, an adapter is also provided to allow the same mount to secure the carpule as well. The mount is arranged and constructed to secure syringes or carpules having a large variety of sizes.
A transducer is used to sense the force or pressure generated by the motor and applied by the plunger within the fluid storage device. In one aspect of the invention, the transducer measures the force between the carpule adapter and the remaining housing of the device. In another aspect of the invention, the transducer includes a size sensing device that senses a change in dimension of an element of the device, said change being indicative of the force or pressure of the drug within the system and the exit pressure. For example, the change in size of the tubing may be used as an indicia of this force or pressure. In another embodiment, the pressure within the tube is measured externally and used as a means of determining the exit pressure.
The motor, the coupling associated with the motor and the electronic controller discussed below is at least partially disposed within the housing for protection.
The fluid storage device is filled and a setup process is initiated during which various operational parameters are calculated, retrieved or received from the clinician. The clinician also specifies the fluid flow rates and peak exit pressure and a total amount of fluid to be dispensed. Then he operates a pneumatic control such as a foot pedal and initiates the fluid flow. Alternatively, commands may be initiated by the clinician either electronically or by voice commands. During dispensing, the output from the transducer is used to calculate the current exit fluid pressure. If this exit pressure approaches a certain threshold, the fluid flow rate is automatically reduced to prevent excessive exit pressure, thereby ensuring that the patient does not suffer undue pain and no tissue is damaged. Several optional features are also provided including aspiration, purging or charging the media with or without air.
Alternatively, the system may be operated in a biopsy mode in which the entry pressure and the outbound or withdrawn fluid flow rate are the relevant control parameters.
Throughout the process, the clinician is provided with constant current information on the ongoing process, both visual and aurally, including the current flow rate, total volume ejected or aspired, exit or entry pressures and other parameters. The slave microprocessor receives commands from the master microprocessor and generates the drive signals required to operate the motor.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a diagram illustrating the major components of the infusion device constructed in accordance with this invention;
FIG. 2 shows an orthogonal view of the drive mechanism of FIG. 1;
FIG. 3 shows internal details of the drive mechanism of FIG. 1;
FIG. 3A shows a block diagram of the electronic controller of FIG. 1;
FIG. 4 shows a side view of the housing of a different type of infusion device with an adapter for pressure sensing;
FIG. 5 shows an end view of the housing of FIG. 4;
FIG. 6 shows an enlarged view of the adapter of FIG. 4;
FIG. 7 shows a somewhat diagrammatic cross-sectional view of the housing of FIG. 4;
FIG. 8 shows an alternate embodiment of a pressure gauge using the size of the tubing;
FIG. 9 shows another embodiment of the pressure gauge using the size of the tubing;
FIG. 10 shows a graph of typical pressure ranges for injections into four different types of tissues.
DETAILED DESCRIPTION OF THE INVENTION
The subject invention pertains to a system for delivering drugs such as an anesthetic, under pressure into a patient's tissues. Importantly, due to a variety of factors, injected fluid disperses through a tissue at different rates, causing the fluid exit pressure to vary. The present inventor has discovered that this exit pressure (or an internal pressure related to the exit pressure) is indicative of, and may be used to identify several types of tissues.
The mechanical assembly for the subject system is illustrated in FIGS. 1 and 2 and the electronic controller 150 for the system is shown in FIG. 3.
A drug delivery system 10 constructed in accordance with this invention includes drive mechanism 12, a delivery tube 14 and a handle 16 terminating with a needle 17. More particularly, a syringe 90 (or other fluid storage device or container) is mounted on the drive mechanism with one end of tube 14 being coupled to the syringe 90. The tube 14, handle 16 and needle 17 in the embodiments of FIGS. 1 to 3, form injection means of the invention for administering the drug fluid at a dynamic exit fluid pressure to a patient tissue type for receiving the drug fluid. The drive mechanism 12 operates a plunger 94 to selectively eject fluid out of the syringe 90, through the tube 14, handle 16, and needle 17 or alternatively to draw fluid in. The drive mechanism 12, plunger 94 and syringe 90 form a pumping mechanism for the device. The drive mechanism 12 is associated with an external controller for selecting various operational parameters discussed in more detail below. This external controller may be provided on the housing of the drive mechanism or may be provided as a separate control unit 18 coupled to the drive mechanism 12 by a cable 20. The control unit 18 may be for instance a PC or laptop computer. Alternatively, the control unit 18 may be internal.
Details of the drive mechanism 12 are seen in FIG. 2. The drive mechanism 12 includes a housing 22 with a top surface 24 and intermediate surface 26 disposed below top surface 24. On surface 26 there is formed a rail 28 extending along the longitudinal axis of housing 22. A platform 30 which is disposed on the rail 28 can be reciprocated back and forth in parallel with said longitudinal axis, as described in more detail below.
On top surface 24 there is a clamp 40. The clamp 40 has a generally C-shaped body. A screw with a head 48 extends through a threaded hole (not shown) in the body of the clamp 40. Platform 30 has a slot 56.
Inside the housing 22, there is provided a motor 66 (FIG. 3). Threaded through the motor 66 there is a worm screw 72. The worm screw 72 is arranged so that as the motor 66 is activated, the worm screw 72 moves in one direction or another, dependent on its direction of rotation, in parallel with the longitudinal aids of the housing 22. One end of the worm screw 72 is non-rotatably attached to a pad 74, coupled to a platform 76. Two short rods 80 are used to couple the pads 74 to platform 76, to prevent the transmission of rotational forces generated by the motor 66 to the platform 76.
Two columns or rods 82, 84 extend between platforms 30 and 76 and secure these two members together. These rods 82, 84 are slidably supported by two pairs of bushings 68, 70 on the housing 22. Except for these bushings, the platforms 76 and 30 are floating respectively inside and outside the housing 22. Rods 82, 84 extend through wall 86 extending between surfaces 24 and 26 via holes (not shown). The rail 28 is hollow and aligned with the worm screw 72 to allow the worm screw 72 to move longitudinally along its axis through the housing 22.
Typically, the syringe 90 has a barrel 92 on surface 24. The barrel 92 has a finger tab resting in a slot formed on the face 24. The finger tab and the slot have been omitted from the drawings for the sake of clarity. The syringe 90 also includes a plunger 94 reciprocated within the barrel 92 by a shaft 93. The shaft terminates in a finger pad 96 resting in slot 56 of platform 30. The syringe 90 is secured to the housing 22 by clamp 40 and screw 48. The syringe terminates with a Luer lock 95 used to connect the syringe to tube 14.
When the motor 66 is activated, as discussed below, it forces the worm screw 72 to move in one direction or another. The worm screw in turn forces the platforms 30, 76 and rods 82 and 84 to move in concert as well, thereby forcing the plunger 94 to reciprocate within the barrel 92. The only elements which move in and out of the housing are the rods 82, 84. Hence most of the critical elements of the system are protected within the housing from tampering, or spilled fluids. Moreover, the drive mechanism 12 is adapted to receive and operate with syringes of various diameters and lengths. Similarly, the delivery tube 14, handle 16 and needle 17 may have any size desired. More details of the syringe and the motor drive, the worm screw and its coupling to the platform 30, are described in U.S. Pat. No. 6,200,289. Moreover, this patent further describes a load cell 78 disposed between platform 76 and pad 74 and arranged to transmit and measure the force between the pad 74 and platform 76. This load cell 78 is bidirectional so that it can measure both stress and strain dependent on whether the worm screw 72 is moving to the left or to the right as determined in FIG. 3. In the present invention other means are disclosed that replace this load cell.
In one embodiment, the apparatus includes a pair of pressure sensors 78A are disposed between finger pad 96 and the walls of slot 56. The sensors 78A are arranged to measure the force applied between the platform 30 and the finger pad 96.
In another embodiment, sensors 78B are provided between the bushings 68 and the sidewalls of the housing 22. In this manner, the sensors 78B can measure the force (or strain) resultant from the force applied by the motor on the syringe plunger 94. Alternatively, a similar load cell may be placed between the syringe tab and the housing 22. The sensors may be load cells, for instance a Model S400 load cell made by the SMD, Inc. of Meridien, Conn.
In yet another embodiment, shown in FIG. 1, the tubing 14 passes through a hole in a size gauge 54. When the tubing 14 is pressurized, it expands, and therefore, the size of the tubing is indicative of the pressure applied thereto by the plunger. The size gauge 54 monitors the size (e.g. cross-sectional dimension, or diameter) of the tubing 14 and provides this parameter to the master controller 18. For example, gauge 54 may include one or more LEDs and an array of light sensors with tubing disposed therebetween. The size of the tubing is determined by the number and/or position of the light sensors occluded by the tubing.
FIG. 8 shows a cross-section of another gauge 54A that may be used instead of gauge 54. It consists of a base B with a slot S holding the tubing T. A hinged cover C holds the tubing T in place. A force sensor FS available off the shelf is inserted through a hole H and rests against the tubing T. As the tubing expands and contracts due to pressure changes, it applies a force on the force sensor. Experimental data shows that this gauge 54A has a fairly linear output and easy to calibrate for various pressures.
FIG. 9 shows another gauge 54B that can be used instead of gauge 54. This gauge is similar to the one in FIG. 8 with the exception that a groove is made in the cover C and the tube is resting on a floating platform P disposed above the force sensor. The force generated by the pressure within the tube is transmitted by the floating platform P to the force sensor FS. Again, the response of this gauge is linear and easy to calibrate.
FIG. 3A shows a block diagram of the electronic controller 150. The controller 150 includes two microprocessors: a master microprocessor 152 and a slave microprocessor 154. Slave microprocessor 154 is used to derive the signals that actually drive the motor 66 and to collect information regarding the position of the platforms 30, 76.
The master microprocessor 152 is used to collect information regarding the rest of the system, including the syringe 90, and its contents, the tube 14, the handle 16 and so on, and to generate control signals for the slave microprocessor 154 necessary for operating the motor 66 to deliver the contents of the syringe 90.
Physically, the slave microprocessor 154 and its associated circuitry are disposed within the housing 22. The master microprocessor 152 is incorporated into control unit 18 which is coupled to the housing 22 through cable 20 as shown in FIG. 1. The microprocessor 152 is associated with a memory 160, input devices 162, display devices 164 and an interface 164.
Memory 160 is used to store programming and data for the master microprocessor 152. More specifically, the memory 160 is used to store six or more data banks, each of said data banks being dedicated to the following information: (a) syringes; (b) tubing; c) needles; (d) fluids; (e) governor parameters; and (f) profiles consisting of a plurality of parameters for a particular procedure to be performed. Each of these parameters is used to determine the control signals generated for the slave microprocessor 154. Each of these data banks contains the appropriate parameters for various commercially available products, or alternatively, parameter data derived using a specific algorithm. Information regarding the various elements for a particular configuration is entered through input devices 102 and is confirmed on the display device 164. These input devices may include a keyboard, a touch screen, a mouse, as well as a microphone. If a microphone is included, voice commands are interpreted by a voice recognition circuit 162A.
The display device 164 is further used to provide an indication as well as instructions on the operation of the system 10. The commands for the operation of motor 66 are generated by master microprocessor 152 and transmitted to an interface 162. Microprocessor 152 is further provided with a speaker 165 used to provide various oral messages, including spoken pre-recorded or synthesized words, (generated by a voice synthesized circuit 165A) chimes, and so on, to provide instructions to the clinician and to provide other information about the current status of the whole system and its elements without the need for the clinician to look at the displays all the time.
The slave microprocessor 154 receives these commands through cable 20 or other connection means and interface 170.
Also associated with the slave microprocessor 154 are one or more position sensors 172 and a chopper drive circuit 174. As previously mentioned, the force or pressure generated within the system is measured by sensors 78A, 78B, 54, 54A, 54B.
Also associated with slave microprocessor 154 is a foot switch or pedal 176. Preferably foot pedal 176 consists of an air chamber with a flexible side wall, said side wall being arranged to change the volume of air and pressure within said chamber in response to activation by a human operator. A pressure sensor (not shown) is part of the foot pedal and is arranged to provide information about said pressure to slave microprocessor 154 via a corresponding A/D converter 190. Foot pedals of this kind are well known in the art and therefore its details have been omitted.
The sequence of operation for the system 10 are similar to the ones described in U.S. Pat. No. 6,200,289 and are not repeated here. Moreover, the algorithm disclosed in said patent is also applicable for converting the parameter obtained from the sensors 78A, 78B or 54 into a corresponding exit pressure.
In another embodiment, the power required to drive motor 66 is monitored. For example, the master controller 150 maybe provided with a power meter P that monitors this power, for example, by measuring the voltage and current applied thereto. This power is, of course, indicative of the force applied by the motor and is used in the same manner as the output of the sensors 78A, 78B or 54.
The system has been described so far as performing an injection process. However, it is obvious to one skilled in the art that it can be used just as effectively to perform a biopsy, for instance to perform a spinal tap, or other similar anaerobic procedures. Essentially the same parameters can be used for this process, with some minor modifications. For instance, instead of defining an exit pressure, the clinician now defines an entry pressure.
In the embodiment discussed so far, it is assumed that a fluid is dispensed from the syringe 90 and, therefore, this syringe 90 must be preloaded with said fluid either by the manufacturer, or must be filled at the site by the clinician or an assistant prior to the start of any operation. In many procedures, however it is more desirable to provide the fluid to be dispensed in a cartridge. Commonly owned U.S. Pat. No. 6,152,734 an injection device is described that includes a housing with a motor driven shaft. On top of the housing, a receptacle is provided for accepting a cartridge holder. The cartridge holder receives a cartridge with an anesthetic. The holder has a top wall connected to the proximal end of a tubing. The distal end of the tubing is used to deliver an anesthetic through its distal end. In accordance with this invention, a sensor module is added on top of the housing. Referring first to FIGS. 4, 5 and 6, the housing 300 has a top surface 302 and a front surface 304. Disposed on the front surface 304 there are a plurality of indication lights and one or more control buttons 308. According to this invention, a sensor module 310 is mounted on top surface 302. This module 310 includes its own upper surface 312 and front surface 314. On front surface 314 there is an LCD display 316.
On the top surface 312 there is provided a receptacle 318 and a hole 320 having the same shape and size as the corresponding elements on the top of the housing 300 described and illustrated in U.S. Pat. No. 6,152,734. Referring now to FIG. 7, attached to module 310 there is a cartridge 322 connected to the proximal end of a tubing 324. The distal end of the tubing 324 is connected to a needle, a catheter or other similar injection means that are similar to the tube 14, handle 16 and needle 17 of the embodiments of FIGS. 1 to 3, for administering the drug fluid at a dynamic exit fluid pressure to a patient tissue type for receiving the drug fluid. When not in use, this injection means can be stored in hole 320. The bottom 326 of the cartridge holder 322 is shaped so that it can be inserted quickly and easily into the receptacle 318 and form an interference fit therewith. As described in U.S. Pat. No. 6,152,734, preferably a quick-connect coupling is provided between the bottom 328 and the receptacle 318 so that the cartridge holder 322 can be quickly and easily installed onto and removed from the receptacle. The cartridge holder 322 holds a cartridge with an anesthetic or other medicinal substance (not shown).
Importantly, according to this invention, one or more sensors 328 are positioned between the bottom 326 of cartridge holder and the walls of receptacle 318. These sensors may be pressure sensors or other similar sensors used to monitor the force applied to the liquid being ejected through tubing 324.
As discussed above, disposed in housing 300 there is a plunger 332, which, with the cartridge 322 and a motor 334, form the pumping mechanism for this embodiment of the invention. Module 312 holds optionally a plunger sensor 330 that is disposed in close proximity to, or in contact with the plunger 332. As the plunger moves upward, its tip enters into the cartridge in the cartridge holder 322 and forces its contents to be ejected through tubing 324. Moving plunger 332 downwardly causes aspiration. The plunger sensor 330 measures the direction and, optionally, the rate of movement of the plunger 332.
This plunger 332 is reciprocated vertically by a motor 334. The motor 334 is controlled by a controller 336. The sensors 328 and 330 are coupled to an interface 338. This interface transmits the information from the sensors 348, 330 to the controller 336. The controller then operates the motor to cause the plunger 332 in the same manner, and using the same algorithm as the plunger 94 in FIGS. 1-4. The information associated with this operation, and any other information are displayed on the display 316.
In this arrangement the sensors may also be used to detect basic operations of the unit such as purging or auto-retraction of this plunger. As the cartridge holder is inserted within the socket of the drive unit the pressure sensors detect their placement and will then automatically purge air from the tubing line readying the system for use. When the cartridge holder is removed from the unit the pressure sensor can detect the removal and allow for automatic retraction of the plunger to the “home” position. Hence, the pressure sensors play a multipurpose role of detecting exit pressure as well as basic operations of the drive unit.
Importantly, the pressure may also be used as criteria to determine the tissue in which fluid is being injected by the device. Previous authors have investigated the clinical implications of interstitial pressure during dental injections. The present inventor has conducted research that demonstrates that using the device described herein, subcutaneous interstitial pressures could be accurately measured and recorded in real-time. It was also determined that a given range of pressures obtained with the device could be readily identified and associated with for specific tissue types. Interstitial pressures generated were correlated to the tissue densities type for particular anatomic locations.
Highly organized densely packed collagen fibers such as those found in certain oral tissues as in the periodontal ligament and gingival hard palate reduced the ability for diffusion of injected fluid, i.e. fluids are contained within a smaller area. This reduced ability for denser tissues to allow rapid re-distribution of the drug results in higher internal pressure during injections. In contrast, loosely organized tissues with a connective stroma composed of a collagen matrix interposed with interstitial fluid and adipose tissues as those found in the mucobuccal fold and infratemperal fossa, result in lower interstitial pressure, as a result of the drug being spread through a larger tissue area.
From this observation, a conjecture was made that there was a correlation between tissue density type and the injection process. More specifically, tests were conducted on the following types of injections:
Group 1—intraligamentary injections (PDL) (a.k.a. periodontal ligament injection), Group 2—the anterior middle superior alveolar palatal injection s(PI), Group 3—the supra-periosteal buccal infiltration (SBI) and Group 4—the inferior alveolar nerve block (IANB). FIG. 10 shows the various pressures obtained during these injections, and clearly illustrates the concept of using pressure (preferably exit pressure) as a means of identifying tissues.
In general, tissues may be categorized into the following types:
Type 1—Low density tissues, comprised of a loosely organized connective tissue matrix interposed with adipose tissue, intercellular fluids and small volumes of organized collagen fibers present. Examples of this tissue type are subcutaneous connective tissues of the maxillary buccal mucosa and infratermporal fossa. Examples of injections performed in these tissue types include; buccal infiltration and inferior alveolar nerve block.
Type 2—Moderate density tissues, comprised of a combination of densely packed collagen fiber bundles interposed with a small amount of glandular tissues and/or adipose tissue. A relatively small amount of intercellular fluids are found in these tissues. Moderate density tissues would also be represented by muscular tissue of the oral cavity. A moderate degree of collagen organization is found in these types of tissues. The tissue types are represented by the attached palatal gingiva, attached gingival tissues or muscle tissues of the oral cavity. Examples of injections performed in these tissue types include; palatal injections or injections into the attached gingiva.
Type 3—High density tissue composed of predominately dense highly organized collagen fiber matrixes. Examples of these types of tissues are the periodontal ligament and the muscle tendon attachments, an example of an injection performed in this tissue type is the PDL injection.
    • Moreover, the use of these techniques can be expanded to identify both mineralized and non-mineralized tissues, and even fluids as follows:
      Non-mineralized tissues:
    • Soft tissues, connective tissues, dermis (skin),
    • Ligaments
    • Adipose tissues (fat)
    • Muscle
    • Tendons
    • Brain tissues
    • Vessels
      Mineralized tissues:
    • Cortical Bone
    • Medullary bone
    • Cartilage
    • Teeth
      Neoplasms:
    • Hard and soft lesions
      Fluid filled lesions
    • Hematomas
    • Cysts
      Fluids: Extacellular and Intra-cellular Fluids
    • Intra-capsular fluids of Joints
    • Intra-cranial fluids
    • Cerebral Spinal fluids
    • Lymph fluid
As described above, the injection device continuously monitors a pressure, and preferably the exit pressure of the fluid during injection. Based on tables stored in its memory, the device is able to determine the type of tissues in which the injection is being injected. This information is displayed to the doctor (or other clinician). The doctor can then confirm that he is performing the injection in the desired tissues. In addition, for each type of tissue, preselected maximum allowable pressure limits and/or flow rates are stored that define either the maximum recommended pressures that patients usually tolerate, or other criteria. The parameters are stored in memory 160. As the pressure approaches this limit, a visual and/or audible alarm is generated for the clinician. In addition, data descriptive of the whole injection process is stored for future analysis, as discussed above.
The techniques described herein are equally applicable to human and animal tissues.
While the invention has been described with reference to several particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles of the invention. Accordingly, the embodiments described in particular should be considered as exemplary, not limiting, with respect to the following claims.

Claims (17)

1. An apparatus comprising:
a housing;
a pumping mechanism in said housing;
a fluid container coupled to said housing and activated by said pumping mechanism to pump a drug fluid, said drug fluid exiting at a dynamic exit fluid pressure, said fluid container including injection means for administering the drug fluid at an exit fluid pressure to a patient tissue type for receiving the drug fluid;
a sensor arranged for determining said exit fluid pressure based on a measured parameter of at least one of said pumping mechanism and said fluid container; and
a controller for receiving said dynamic exit fluid pressure and having at least one memory data bank and at least one microprocessor, said memory data bank storing a plurality of known interstitial fluid pressures corresponding to different patient tissue types, the memory data bank also storing the measured parameter, said microprocessor generating an output based on the measured parameter and the patient tissue type for receiving said drug fluid and for correlating said exit fluid pressure to one of said known interstitial fluid pressures.
2. The apparatus of claim 1 further comprising: a pressure sensor for sensing a pressure within said pumping mechanism and a calculator for receiving said pressure within said pumping mechanism, and for deriving said exit fluid pressure.
3. The apparatus of claim 1 further comprising: said memory data bank containing information correlating exit fluid pressures to tissue types, wherein said controller receives said exit fluid pressure, compares said exit fluid pressure to said information and generates said output in accordance with said information, the tissue types being selected from the group consisting of: low density loosely organized connective tissue matrix interposed with adipose tissue, intercellular fluids and organized collagen fibers; medium density packed collagen fiber bundles interposed with glandular tissues and/or adipose tissue; muscular tissue; high density tissue composed of predominately dense highly organized collagen fiber matrixes; and mineralized tissue.
4. An apparatus comprising:
a pumping mechanism;
a fluid container coupled to said pumping mechanism to pump a drug fluid, said fluid exiting at a dynamic exit fluid pressure into a selected biological tissue type;
a sensor arranged to enable sensing and identification of specific biological tissue types based on the exit fluid pressures; and
a controller for receiving said dynamic exit fluid pressure and having at least one memory data bank and at least one microprocessor, said memory data bank storing a plurality of known interstitial fluid pressures corresponding to different biological tissue types, the memory data bank also storing measured parameters of at least one of said pumping mechanism and said fluid container, said microprocessor generating an output based on the measured parameter and the biological tissue type and for correlating said exit fluid pressure to one of said known interstitial fluid pressures.
5. The apparatus of claim 4; wherein said pumping mechanism includes: a container holding said drug fluid, a plunger reciprocating within said container and a motor responsive to signals from said controller and driving said plunger.
6. The apparatus of claim 5; wherein said sensor is disposed between said motor and said plunger to sense a force applied to said plunger.
7. The apparatus of claim 5; wherein said pumping mechanism includes: a flexible tubing leading said drug fluid to the biological tissue, and wherein said sensor is coupled to said flexible tubing.
8. The apparatus of claim 7; wherein said sensor includes: a size sensor sensing a dimension of said tubing.
9. The apparatus of claim 8; wherein said sensor includes: a light source and a light sensor, said light sensor generating an output indicative of an internal pressure within the tubing.
10. The apparatus of claim 7; wherein said tubing expands and contracts radially in response to the exit fluid pressure; and wherein said sensor includes: a tubing holder holding at least a portion of said tubing in a preselected position and a force sensor activated by said portion within said holder.
11. The apparatus of claim 10; wherein said holder includes: a base with a slot holding the tubing portion, a cover folded over said base and holding said tubing in said trough.
12. The apparatus of claim 11; wherein said holder includes: a base, a floating plate resting on said base, and a cover holding said tubing portion with said floating plate.
13. The apparatus of claim 12 further comprising:
a force sensor for sensing a force between the floating plate and said base.
14. The apparatus of claim 11 further comprising: a hole passing to said slot with said force sensor being disposed in said hole.
15. The apparatus of claim 4 further comprising: a power source providing power to said pumping mechanism, wherein said sensor determines the power provided to the pumping mechanism to determine said exit fluid pressure.
16. The apparatus of claim 4 further comprising: a housing and said pumping mechanism includes a cartridge holding said fluid.
17. The apparatus of claim 16; wherein said sensor includes: a load sensor disposed between said housing and said cartridge holder.
US10/827,969 1998-04-10 2004-04-20 Drug infusion device with tissue identification using pressure sensing Expired - Lifetime US7449008B2 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
US10/827,969 US7449008B2 (en) 1998-04-10 2004-04-20 Drug infusion device with tissue identification using pressure sensing
AT04783761T ATE447996T1 (en) 2003-09-12 2004-09-13 DRUG INFUSION DEVICE WITH TISSUE IDENTIFICATION USING PRESSURE DETECTION
MXPA06002764A MXPA06002764A (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing.
CN200480030713A CN100581613C (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
CA2539106A CA2539106C (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
DE602004024098T DE602004024098D1 (en) 2003-09-12 2004-09-13 MEDICINAL INFUSION DEVICE WITH TISSUE IDENTIFICATION USING PRESSURE DETECTION
PCT/US2004/029665 WO2005027992A2 (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
BRPI0414352A BRPI0414352B8 (en) 2003-09-12 2004-09-13 injection apparatus
ES04783761T ES2335348T3 (en) 2003-09-12 2004-09-13 DRUG INFUSION DEVICE WITH FABRIC IDENTIFICATION USING PRESSURE DETECTION.
DK04783761.2T DK1670522T3 (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification that uses pressure sensing
PL04783761T PL1670522T3 (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
EP04783761A EP1670522B1 (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
KR1020067006951A KR101104523B1 (en) 2003-09-12 2004-09-13 Drug infusion device with tissue identification using pressure sensing
JP2006526333A JP4722849B2 (en) 2003-09-12 2004-09-13 Drug injection device that identifies tissue using pressure sensing
US11/208,400 US20060122555A1 (en) 1998-04-10 2005-08-19 Drug infusion device for neural axial and peripheral nerve tissue identification using exit pressure sensing
US11/271,563 US7625354B2 (en) 1998-04-10 2005-11-11 Handpiece for fluid administration apparatus
IL174302A IL174302A (en) 2003-09-12 2006-03-13 Drug infusion device with tissue identification using pressure sensing
HK07110728.1A HK1106457A1 (en) 2003-09-12 2007-10-04 Drug infusion device with tissue identification using pressure sensing

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8138898P 1998-04-10 1998-04-10
US09/201,464 US6200289B1 (en) 1998-04-10 1998-11-30 Pressure/force computer controlled drug delivery system and the like
US09/766,772 US6786885B2 (en) 1998-04-10 2001-01-22 Pressure/force computer controlled drug delivery system with exit pressure control
US50237903P 2003-09-12 2003-09-12
US10/827,969 US7449008B2 (en) 1998-04-10 2004-04-20 Drug infusion device with tissue identification using pressure sensing

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/766,772 Continuation-In-Part US6786885B2 (en) 1998-04-10 2001-01-22 Pressure/force computer controlled drug delivery system with exit pressure control

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/208,400 Continuation-In-Part US20060122555A1 (en) 1998-04-10 2005-08-19 Drug infusion device for neural axial and peripheral nerve tissue identification using exit pressure sensing
US11/271,563 Continuation-In-Part US7625354B2 (en) 1998-04-10 2005-11-11 Handpiece for fluid administration apparatus

Publications (2)

Publication Number Publication Date
US20050004514A1 US20050004514A1 (en) 2005-01-06
US7449008B2 true US7449008B2 (en) 2008-11-11

Family

ID=34381049

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/827,969 Expired - Lifetime US7449008B2 (en) 1998-04-10 2004-04-20 Drug infusion device with tissue identification using pressure sensing

Country Status (14)

Country Link
US (1) US7449008B2 (en)
EP (1) EP1670522B1 (en)
KR (1) KR101104523B1 (en)
CN (1) CN100581613C (en)
AT (1) ATE447996T1 (en)
BR (1) BRPI0414352B8 (en)
CA (1) CA2539106C (en)
DE (1) DE602004024098D1 (en)
DK (1) DK1670522T3 (en)
ES (1) ES2335348T3 (en)
IL (1) IL174302A (en)
MX (1) MXPA06002764A (en)
PL (1) PL1670522T3 (en)
WO (1) WO2005027992A2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100036379A1 (en) * 2008-02-07 2010-02-11 Tyco Healthcare Group Lp Endoscopic Instrument for Tissue Identification
KR100955988B1 (en) * 2009-09-25 2010-05-04 윤태진 Automatic fat injection device
WO2010118043A1 (en) * 2009-04-06 2010-10-14 Harvard Apparatus, Inc. Improvements in laboratory syringe pumps
US8002736B2 (en) 2007-12-21 2011-08-23 Carticept Medical, Inc. Injection systems for delivery of fluids to joints
US20120202165A1 (en) * 2009-08-12 2012-08-09 Ashish Kakar Apparatus and method for measuring dentin hypersensitivity
US8545440B2 (en) 2007-12-21 2013-10-01 Carticept Medical, Inc. Injection system for delivering multiple fluids within the anatomy
US9044542B2 (en) 2007-12-21 2015-06-02 Carticept Medical, Inc. Imaging-guided anesthesia injection systems and methods
US20160030663A1 (en) * 2013-03-15 2016-02-04 Concert Medical, Llc Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US9483615B2 (en) 2007-08-10 2016-11-01 Smiths Medical Asd, Inc. Communication of original and updated pump parameters for a medical infusion pump
EP3446732A1 (en) 2012-07-03 2019-02-27 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow with identification of and injection into fluid-filled anatomic spaces
US10220180B2 (en) 2015-10-16 2019-03-05 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
USD859634S1 (en) * 2015-01-02 2019-09-10 Milestone Scientific Inc. Intra-articular injection device
US10463829B2 (en) * 2014-06-02 2019-11-05 The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust Regional anaesthesia injection apparatus
US10632255B2 (en) 2017-02-15 2020-04-28 Milestone Scientific, Inc. Drug infusion device
US10646660B1 (en) 2019-05-16 2020-05-12 Milestone Scientific, Inc. Device and method for identification of a target region
US11471595B2 (en) 2017-05-04 2022-10-18 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060122555A1 (en) * 1998-04-10 2006-06-08 Mark Hochman Drug infusion device for neural axial and peripheral nerve tissue identification using exit pressure sensing
US7625354B2 (en) 1998-04-10 2009-12-01 Milestone Scientific, Inc. Handpiece for fluid administration apparatus
US7618409B2 (en) * 2006-12-21 2009-11-17 Milestone Scientific, Inc Computer controlled drug delivery system with dynamic pressure sensing
US8684968B2 (en) * 2006-12-29 2014-04-01 Aktivpak, Inc. Hypodermic drug delivery reservoir and apparatus
US11058354B2 (en) 2007-03-19 2021-07-13 University Of Virginia Patent Foundation Access needle with direct visualization and related methods
US9468396B2 (en) * 2007-03-19 2016-10-18 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
CA2680639C (en) * 2007-03-19 2017-03-07 University Of Virginia Patent Foundation Access needle pressure sensor device and method of use
WO2011103456A2 (en) 2010-02-18 2011-08-25 University Of Virginia Patent Foundation System, method, and computer program product for simulating epicardial electrophysiology procedures
US7740612B2 (en) * 2007-07-27 2010-06-22 Milestone Scientific, Inc Self-administration injection system
CA2695996A1 (en) * 2007-08-16 2009-02-19 East Carolina University Smart injection syringe systems providing real-time user feedback of correct needle position
KR100896797B1 (en) * 2007-09-14 2009-05-11 정선근 System and method for injecting liquid material into living body
RU2010131797A (en) 2007-12-28 2012-02-10 Эктивпак, Инк. (Us) DOSER AND PACKAGING OF MEDICINES SUITABLE FOR ADMINISTRATION OF THE MEDICINE IN THE OBJECT OF TREATMENT
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
US9642534B2 (en) 2009-09-11 2017-05-09 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
FR2952682B1 (en) * 2009-11-13 2017-08-25 Pulssar Tech DEVICE FOR MONITORING A SAMPLING USING A PISTON PUMP.
US9744300B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Syringe pump and related method
US9789247B2 (en) 2011-12-21 2017-10-17 Deka Products Limited Partnership Syringe pump, and related method and system
US9295778B2 (en) 2011-12-21 2016-03-29 Deka Products Limited Partnership Syringe pump
ES2553875T3 (en) * 2010-11-24 2015-12-14 Liebel-Flarsheim Company Llc Medical fluid injector system
US20140081208A1 (en) * 2011-05-11 2014-03-20 Isto Technologies, Inc. Injection pressure monitoring device and system
US10722645B2 (en) 2011-12-21 2020-07-28 Deka Products Limited Partnership Syringe pump, and related method and system
US11217340B2 (en) 2011-12-21 2022-01-04 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CN102764469B (en) * 2012-07-05 2014-06-25 深圳圣诺医疗设备有限公司 Automatic calibration method and system for pressure of injection pump
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9180243B2 (en) * 2013-03-15 2015-11-10 Tandem Diabetes Care, Inc. Detection of infusion pump conditions
KR101448679B1 (en) 2013-06-26 2014-10-08 (주)디앤케이 Apparatus for drug leakage protection and method thereof
US9052246B2 (en) * 2013-11-14 2015-06-09 Honeywell International Inc. Force sensor using integral force biasing for improved linearity
EP3622983B1 (en) * 2014-02-21 2024-01-03 DEKA Products Limited Partnership Syringe pump having a pressure sensor assembly
EP3212256A4 (en) 2014-10-28 2018-07-18 Bayer HealthCare LLC Self-orienting pressure jacket and pressure jacket-to-injector interface
US9199033B1 (en) 2014-10-28 2015-12-01 Bayer Healthcare Llc Self-orienting syringe and syringe interface
CN112451785A (en) 2014-10-28 2021-03-09 拜耳医药保健有限公司 Self-orienting pressure jacket and interface of pressure jacket to syringe
NO2689315T3 (en) 2014-10-28 2018-04-14
EP3374002A1 (en) 2015-11-13 2018-09-19 Bayer Healthcare LLC Nested syringe assembly
WO2018117584A1 (en) * 2016-12-19 2018-06-28 전북대학교산학협력단 Automatic injection device and automatic injection system
JP7252143B2 (en) * 2017-08-31 2023-04-04 バイエル・ヘルスケア・エルエルシー System and method for mechanical calibration of drive member position and fluid injector system
KR101888352B1 (en) * 2017-10-03 2018-08-14 김준태 Medicine automatic injection apparatus
EP4316551A2 (en) * 2017-11-14 2024-02-07 Becton, Dickinson and Company Electronic modules for a syringe
US11191893B2 (en) 2018-01-31 2021-12-07 Bayer Healthcare Llc System and method for syringe engagement with injector
CN108577945A (en) * 2018-05-16 2018-09-28 张拴军 Nerve block anesthesia intelligent robot auxiliary system
US11850395B2 (en) * 2018-05-17 2023-12-26 Carefusion 303, Inc. Syringe driver for infusion
FR3092001A1 (en) * 2019-01-24 2020-07-31 Eveon ASSISTED MANUAL INJECTION DEVICE FOR INJECTING A COMPOSITION CONTAINED IN A CONTAINER
KR102218149B1 (en) * 2019-04-24 2021-02-23 주식회사 삼육오엠씨네트웍스 Automatic fat injection apparatus for graft
CN114096293A (en) * 2019-07-01 2022-02-25 西医药服务有限公司 System and method for measuring fluid flow from a syringe
CN112336423B (en) * 2020-10-20 2022-08-23 深圳尚奥医疗科技有限公司 Puncture auxiliary assembly and puncture device
WO2022170956A1 (en) * 2021-02-09 2022-08-18 杭州堃博生物科技有限公司 Device and method for adjusting torque of push handle of syringe, and injection pump
CN113456936B (en) * 2021-07-05 2022-02-08 联赢医疗科技有限公司 Control system of infusion pump

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215699A (en) 1978-04-03 1980-08-05 The Kendall Company Position indicating device
US5295967A (en) * 1992-09-23 1994-03-22 Becton, Dickinson And Company Syringe pump having continuous pressure monitoring and display
US5425716A (en) 1991-08-09 1995-06-20 Atom Kabushiki Kaisha Infusion apparatus
US5902273A (en) 1997-10-15 1999-05-11 Yang; Ian Y. Pressurizable epidural space identification syringe
US6113574A (en) 1998-07-27 2000-09-05 Spinello; Ronald P. Anesthetic injection apparatus and methods
US6159161A (en) 1995-10-20 2000-12-12 Hodosh; Milton Microprocessor-controlled fluid dispensing apparatus
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US6494882B1 (en) * 2000-07-25 2002-12-17 Verimetra, Inc. Cutting instrument having integrated sensors
US20040215080A1 (en) 2001-06-20 2004-10-28 Timotheus Joan Marie Lechner Device and method for locating anatomical cavity in a body

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314664C2 (en) * 1983-04-22 1985-02-21 B. Braun Melsungen Ag, 3508 Melsungen Procedure for triggering a pre-alarm in a pressure infusion apparatus
US5180371A (en) 1986-05-30 1993-01-19 Spintech, Inc. Hypodermic anesthetic injection apparatus and method
JPH0731092A (en) * 1993-07-09 1995-01-31 Nikkiso Co Ltd Slim motor for canned motor pump
JPH08243159A (en) * 1995-03-10 1996-09-24 Musashi Eng:Kk Liquid pressure monitor device
US5672155A (en) * 1996-06-14 1997-09-30 Riley; Robert Q. Fluid transfer apparatus
US6200289B1 (en) * 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215699A (en) 1978-04-03 1980-08-05 The Kendall Company Position indicating device
US5425716A (en) 1991-08-09 1995-06-20 Atom Kabushiki Kaisha Infusion apparatus
US5295967A (en) * 1992-09-23 1994-03-22 Becton, Dickinson And Company Syringe pump having continuous pressure monitoring and display
US6159161A (en) 1995-10-20 2000-12-12 Hodosh; Milton Microprocessor-controlled fluid dispensing apparatus
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US5902273A (en) 1997-10-15 1999-05-11 Yang; Ian Y. Pressurizable epidural space identification syringe
US6113574A (en) 1998-07-27 2000-09-05 Spinello; Ronald P. Anesthetic injection apparatus and methods
US6494882B1 (en) * 2000-07-25 2002-12-17 Verimetra, Inc. Cutting instrument having integrated sensors
US20040215080A1 (en) 2001-06-20 2004-10-28 Timotheus Joan Marie Lechner Device and method for locating anatomical cavity in a body

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9483615B2 (en) 2007-08-10 2016-11-01 Smiths Medical Asd, Inc. Communication of original and updated pump parameters for a medical infusion pump
US8425463B2 (en) 2007-12-21 2013-04-23 Carticept Medical, Inc. Anesthetic injection system
US9398894B2 (en) 2007-12-21 2016-07-26 Carticept Medical, Inc. Removable cassette for articular injection system
US8545440B2 (en) 2007-12-21 2013-10-01 Carticept Medical, Inc. Injection system for delivering multiple fluids within the anatomy
US8002736B2 (en) 2007-12-21 2011-08-23 Carticept Medical, Inc. Injection systems for delivery of fluids to joints
US9067015B2 (en) 2007-12-21 2015-06-30 Carticept Medical, Inc. System for injecting fluids in a subject
US8079976B2 (en) 2007-12-21 2011-12-20 Carticept Medical, Inc. Articular injection system
US8142414B2 (en) 2007-12-21 2012-03-27 Carticept Medical, Inc. Methods of injecting fluids into joints using a handpiece assembly
US9044542B2 (en) 2007-12-21 2015-06-02 Carticept Medical, Inc. Imaging-guided anesthesia injection systems and methods
US20120179036A1 (en) * 2007-12-21 2012-07-12 Carticept Medical, Inc. Imaging-guided joint injection system
US8007487B2 (en) 2007-12-21 2011-08-30 Carticept Medical, Inc. Method of treating a joint using an articular injection system
US8425464B2 (en) 2007-12-21 2013-04-23 Carticept Medical, Inc. Imaging-guided anesthetic injection method
US9370314B2 (en) 2008-02-07 2016-06-21 Covidien Lp Endoscopic instrument for tissue identification
US20100036379A1 (en) * 2008-02-07 2010-02-11 Tyco Healthcare Group Lp Endoscopic Instrument for Tissue Identification
US11540873B2 (en) 2008-02-07 2023-01-03 Covidien Lp Surgical instrument for tissue identification
US8221418B2 (en) 2008-02-07 2012-07-17 Tyco Healthcare Group Lp Endoscopic instrument for tissue identification
US8801709B2 (en) 2008-02-07 2014-08-12 Covidien Lp Endoscopic instrument for tissue identification
US10631922B2 (en) 2008-02-07 2020-04-28 Covidien Lp Endoscopic instrument for tissue identification
US10045814B2 (en) 2008-02-07 2018-08-14 Covidien Lp Endoscopic instrument for tissue identification
US20110087166A1 (en) * 2009-04-06 2011-04-14 Mark Davis Laboratory syringe pumps
WO2010118043A1 (en) * 2009-04-06 2010-10-14 Harvard Apparatus, Inc. Improvements in laboratory syringe pumps
US8579630B2 (en) * 2009-08-12 2013-11-12 Ashish Kakar Apparatus and method for measuring dentin hypersensitivity
US20120202165A1 (en) * 2009-08-12 2012-08-09 Ashish Kakar Apparatus and method for measuring dentin hypersensitivity
KR100955988B1 (en) * 2009-09-25 2010-05-04 윤태진 Automatic fat injection device
EP3446732A1 (en) 2012-07-03 2019-02-27 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow with identification of and injection into fluid-filled anatomic spaces
US10946139B2 (en) 2012-07-03 2021-03-16 Milestone Scientific, Inc. Disposable assembly for drug infusion with pressure sensing for identification of and injection into fluid-filled anatomic spaces
US20160030663A1 (en) * 2013-03-15 2016-02-04 Concert Medical, Llc Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US10420882B2 (en) * 2013-03-15 2019-09-24 Medovate Limited Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US11712515B2 (en) 2013-03-15 2023-08-01 Medovate Limited Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US10463829B2 (en) * 2014-06-02 2019-11-05 The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust Regional anaesthesia injection apparatus
US11129935B2 (en) * 2014-06-02 2021-09-28 The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust Regional anaesthesia injection apparatus
USD859634S1 (en) * 2015-01-02 2019-09-10 Milestone Scientific Inc. Intra-articular injection device
US10842966B2 (en) 2015-10-16 2020-11-24 Milestone Scientific, Inc. Apparatus for assisting a user in advancing a needle into a subject at a selected rate
US10220180B2 (en) 2015-10-16 2019-03-05 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
US10632255B2 (en) 2017-02-15 2020-04-28 Milestone Scientific, Inc. Drug infusion device
US11471595B2 (en) 2017-05-04 2022-10-18 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
US10646660B1 (en) 2019-05-16 2020-05-12 Milestone Scientific, Inc. Device and method for identification of a target region
US10960141B1 (en) 2019-05-16 2021-03-30 Milestone Scientific, Inc. Device and method for identification of a target region
US11147927B2 (en) 2019-05-16 2021-10-19 Milestone Scientific, Inc. Device and method for identification of a target region

Also Published As

Publication number Publication date
KR101104523B1 (en) 2012-01-12
BRPI0414352B8 (en) 2021-06-22
MXPA06002764A (en) 2006-06-14
EP1670522A2 (en) 2006-06-21
ES2335348T3 (en) 2010-03-25
CN1997422A (en) 2007-07-11
EP1670522B1 (en) 2009-11-11
EP1670522A4 (en) 2007-09-12
WO2005027992A3 (en) 2006-06-01
CN100581613C (en) 2010-01-20
IL174302A (en) 2013-01-31
DK1670522T3 (en) 2010-03-29
WO2005027992A2 (en) 2005-03-31
PL1670522T3 (en) 2010-04-30
CA2539106C (en) 2011-12-06
BRPI0414352B1 (en) 2015-11-24
US20050004514A1 (en) 2005-01-06
KR20060121916A (en) 2006-11-29
BRPI0414352A (en) 2006-11-14
ATE447996T1 (en) 2009-11-15
CA2539106A1 (en) 2005-03-31
DE602004024098D1 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
US7449008B2 (en) Drug infusion device with tissue identification using pressure sensing
JP4722849B2 (en) Drug injection device that identifies tissue using pressure sensing
US20060122555A1 (en) Drug infusion device for neural axial and peripheral nerve tissue identification using exit pressure sensing
US10946139B2 (en) Disposable assembly for drug infusion with pressure sensing for identification of and injection into fluid-filled anatomic spaces
US6786885B2 (en) Pressure/force computer controlled drug delivery system with exit pressure control
US9504790B1 (en) Device and method for identification of a target region

Legal Events

Date Code Title Description
AS Assignment

Owner name: MILESTONE SCIENTIFIC, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOCHMAN, MARK N.;REEL/FRAME:015183/0247

Effective date: 20040902

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2553); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 12